You say Either, I say either, but let's not call the whole thing off: Models for predicting the risk of lymph node involvement in patients with prostate cancer
- 1 February 1996
- journal article
- editorial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 34 (3) , 749-751
- https://doi.org/10.1016/0360-3016(95)02295-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Predicting the patient at low risk for lymph node metastasis with localized prostate cancer: An analysis of four statistical modelsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Incidence of Occult Lymph Node Metastases in Pathological Stage C (pT3NO) Prostate CancerJournal of Urology, 1995
- Re: The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer, by A. W. Partin, J. Yoo, H. B. Carter, J. D. Pearson, D. W. Chan, J. I. Epstein and P. C. Walsh, J. Urol., 150: 110–115, 1993Journal of Urology, 1994
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Re: The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer, by A. W. Partin, J. Yoo, H. B. Carter, J. D. Pearson, D. W. Chan, J. I. Epstein and P. C. Walsh, J. Urol., 150: 110-114, 1993Journal of Urology, 1993
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate CancerJournal of Urology, 1993
- Extended Pelvic Lymphadenectomy for Prostatic CancerJournal of Urology, 1979